141 related articles for article (PubMed ID: 38825674)
1. Pan-cancer analysis of the TRAF family genes and their correlation with prognosis, TME, immune and drug sensitivity.
Yao B; Hu W; Chen Y; Li J; Jiang K; Dou J
Eur J Med Res; 2024 Jun; 29(1):307. PubMed ID: 38825674
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.
Yuan Z; Li B; Liao W; Kang D; Deng X; Tang H; Xie J; Hu D; Chen A
Front Immunol; 2024; 15():1382520. PubMed ID: 38698857
[TBL] [Abstract][Full Text] [Related]
4. A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance.
Zhang Q; Luo Y; Qian B; Cao X; Xu C; Guo K; Wan R; Jiang Y; Wang T; Mei Z; Liu J; Lv C
Aging (Albany NY); 2024 May; 16(9):8000-8018. PubMed ID: 38709280
[TBL] [Abstract][Full Text] [Related]
5. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
6. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
[TBL] [Abstract][Full Text] [Related]
8. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
9. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
Yang B; Wang Y; Liu T; Zhang M; Luo T
Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity.
Chen Z; Zhao Y; Tian Y; Cao R; Shang D
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830651
[TBL] [Abstract][Full Text] [Related]
12. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
Front Immunol; 2021; 12():812713. PubMed ID: 35069601
[TBL] [Abstract][Full Text] [Related]
13. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
Front Immunol; 2022; 13():900273. PubMed ID: 36159856
[TBL] [Abstract][Full Text] [Related]
15. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer.
Yang L; Tang Y; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
Sci Rep; 2024 Apr; 14(1):9570. PubMed ID: 38671021
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning Identifies Pan-Cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
Song Y; Sun Y; Sun T; Tang R
Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
Zhang X; Klamer B; Li J; Fernandez S; Li L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
[TBL] [Abstract][Full Text] [Related]
20. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
